GlassScriptPhysician profile
Ngoc B Tran
NPI 1528318342
$1,623.31
in general payments reported to CMS, 2019-2025
16 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $538 · 2022: $341 · 2023: $41.22 · 2024: $389 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $259.78 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nalu Medical, INC. | $151.57 | 2022 | |
| Spinal Simplicity, LLC | $142.88 | 2025 | Ha Minuteman G3-R |
| Grt US Holding, INC. | $140.31 | 2022 | |
| Vertos Medical, INC. | $139.52 | 2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $135.44 | 2021-2025 | Relistor |
| Foundation Fusion Solutions, LLC | $124.03 | 2024 | |
| Abbvie INC. | $99.99 | 2021 | |
| Novo Nordisk INC | $99.14 | 2021 | |
| Collegium Pharmaceutical, INC. | $91.91 | 2021-2023 | Belbuca |
| Uswm, LLC | $90.76 | 2021 | |
| Forte Bio-Pharma LLC | $47.26 | 2021 | |
| Lilly USA, LLC | $33.58 | 2021 | |
| Arbor Pharmaceuticals, INC. | $30.71 | 2021 | |
| Radius Health, INC. | $21.64 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $14.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ngoc Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.